Darius Kharabi - 15 Nov 2021 Form 3 Insider Report for Kala Pharmaceuticals, Inc. (KALA)

Role: CHIEF BUSINESS OFFICER
Signature: /s/ Eric Trachtenberg, Attorney-in-Fact
Issuer symbol: KALA
Transactions as of: 15 Nov 2021
Transactions value $: $0
Form type: 3
Filing time: 17 Nov 2021, 19:02:11 UTC
Next filing: 06 Jan 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24.1 - Power of Attorney